Who Paid My Doc
Randheer Shailam
Diagnostic Radiology Boston, MA Medical Doctor
NPI 1558352278 CMS profile 663987
55 Fruit St, Ell 2 Radiological Associates, Boston, MA 02114
General payments
$86,406
Research payments
$71,093
Ownership & investment interest
$0
Research they led as principal investigator
$305,806
Through program year 2025, Randheer Shailam of Boston, MA is reported in the CMS Open Payments database as having received $86,406 across 67 general payments and $71,093 in research payments paid to them. Separately, studies naming them as principal investigator received $305,806 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | Research | $13,280 | 13 | |
| 2024 | General | $25,788 | 3 | |
| 2024 | Research | $27,000 | 14 | |
| 2023 | General | $1,000 | 1 | |
| 2023 | Research | $3,600 | 5 | |
| 2021 | General | $20,350 | 23 | |
| 2021 | Research | $875 | 1 | |
| 2020 | General | $38,068 | 30 | |
| 2020 | Research | $26,338 | 5 | |
| 2019 | General | $1,200 | 10 |
Beside peers
- Randheer Shailam
- Diagnostic Radiology median
- Middle half of Diagnostic Radiology
- National median
In program year 2025, general payments to Randheer Shailam were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.
Show as a table
| Year | Randheer Shailam | Diagnostic Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,200 | $108 | $29–$318 | $163 |
| 2020 | $38,068 | $65 | $21–$252 | $114 |
| 2021 | $20,350 | $92 | $24–$292 | $132 |
| 2022 | $0 | $104 | $29–$294 | $149 |
| 2023 | $1,000 | $110 | $29–$337 | $160 |
| 2024 | $25,788 | $113 | $30–$356 | $164 |
| 2025 | $0 | $112 | $32–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
105 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Radiology in Massachusetts
Gregg Miller
Diagnostic Radiology · Boston, MA
Ali Guermazi
Diagnostic Radiology · West Roxbury, MA
Stephan Anderson
Diagnostic Radiology · Boston, MA
Ajay Wakhloo
Diagnostic Radiology · Worcester, MA
Ashraf Thabet
Diagnostic Radiology · Boston, MA
Mukesh Harisinghani
Diagnostic Radiology · Boston, MA
Related records
Diagnostic Radiology in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Radiology
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.